Signaling involved in pituitary adenylate cyclase-activating polypeptide-stimulated ADNP expression
Authors:
- Min LiMLMin Li
- Seiji ShiodaSSSeiji Shioda
- Akira ArimuraAAAkira Arimura
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Transport of Pituitary Adenylate Cyclase-Activating Polypeptide Across the Blood-Brain Barrier and the Prevention of Ischemia-Induced Death of Hippocampal NeuronsAnnals of the New York Academy of Sciences, 2006
- Activation of the neuroprotective ERK signaling pathway by fructose-1,6-bisphosphate during hypoxia involves intracellular Ca2+ and phospholipase CBrain Research, 2002
- Chemokine release is associated with the protective action of PACAP-38 against HIV envelope protein neurotoxicityNeuropeptides, 2002
- A Novel VIP Responsive Gene: Activity Dependent Neuroprotective ProteinAnnals of the New York Academy of Sciences, 2000
- Complete Sequence of a Novel Protein Containing a Femtomolar‐Activity‐Dependent Neuroprotective PeptideJournal of Neurochemistry, 1999
- Perspectives on Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) in the Neuroendocrine, Endocrine, and Nervous SystemsThe Japanese Journal of Physiology, 1998
- Identification of VIP/PACAP receptors on rat astrocytes using antisense oligodeoxynucleotidesJournal of Molecular Neuroscience, 1997
- PACAP Functions as a Neurotrophic FactoraAnnals of the New York Academy of Sciences, 1994
- Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptideNature, 1988
- Nonneuronal cells mediate neurotrophic action of vasoactive intestinal peptide.Journal of Cell Biology, 1987